Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11672791
Tyrosine kinase inhibitors
granted -
US 11672793
Compositions of CXCR4 inhibitors and methods of preparation and use
granted -
US 11672774
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
granted -
US 11666606
Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases
granted -
US 11667637
Fused imidazo-piperidine JAK inhibitors
granted -
US 11667643
RIP1K inhibitors
granted -
US 11666645
CD200 inhibitors and methods of use thereof
granted -
US 11661426
Imidazole-containing inhibitors of ALK2 kinase
granted -
US 11661401
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
granted -
US 11654147
ALK2 inhibitors and methods for inhibiting BMP signaling
granted -
US 11654157
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation
granted -
US 11654142
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11649251
Substituted inhibitors of menin-MLL and methods of use
granted -
US 11643388
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
granted -
US 11639355
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors
granted -
US 11639364
Potent sialyltransferase inhibitors
granted -
US 11634413
Neprilysin inhibitors
granted -
US 11629145
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 11622970
BCL-2 inhibitors and their use as pharmaceuticals
granted -
US 11617742
Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
granted -
US 11618746
Inhibitors of APOL1 and methods of using same
granted -
US 11618731
Prodrugs of kallikrein inhibitors
granted -
US 11613527
Enzyme inhibitors
granted -
US 11613528
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted